Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt issuances
Ratios

Cresco Labs (CRLBF) Receivables - Other (2019 - 2022)

Cresco Labs filings provide 3 years of Receivables - Other readings, the most recent being $1.0 million for Q1 2022.

  • On a quarterly basis, Receivables - Other changed N/A to $1.0 million in Q1 2022 year-over-year; TTM through Dec 2020 was $200000.0, a 71.43% decrease, with the full-year FY2022 number at $300000.0, changed N/A from a year prior.
  • Receivables - Other hit $1.0 million in Q1 2022 for Cresco Labs, up from $200000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $1.0 million in Q1 2022 to a low of $200000.0 in Q4 2020.
  • Median Receivables - Other over the past 3 years was $700000.0 (2019), compared with a mean of $633333.3.
  • The widest YoY moves for Receivables - Other: up 71.43% in 2020, down 71.43% in 2020.
  • Cresco Labs' Receivables - Other stood at $700000.0 in 2019, then tumbled by 71.43% to $200000.0 in 2020, then surged by 400.0% to $1.0 million in 2022.
  • The last three reported values for Receivables - Other were $1.0 million (Q1 2022), $200000.0 (Q4 2020), and $700000.0 (Q4 2019) per Business Quant data.